Stock screener

IBB

Conviction 79Scan · Thu, Sep 24, 2026

iShares Biotechnology ETF (IBB) closed at $209.21 (+1.26%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 55, RS Rating 88, -3.6% from its 52-week high, +23.8% year to date.

IBB$209.21+1.26%
ResistanceSupportVol 14
63 bars
Vol MA14 1.49M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
iShares Biotechnology ETF
Price209.21
Change+1.26%
Gap-0.40%
Rel volume0.66×
Avg volume1.48M
Avg $ vol307.31M
SMA 20207.80
SMA 50201.32
SMA 200179.86
Price vs 50+3.92%
Price vs 200+16.32%
MA stackbullish
50/200 cross—
Supertrendup · 202.00
RSI (14)55
MACD hist-0.31
MACD cross—
Stoch %K / %D68 / 60
ADX (14)18
+DI / −DI24 / 19
RSI divergence—
MACD divergence—
ATR %1.94%
ADR %1.70%
52w high216.96
52w low139.07
From 52w high-3.57%
Above 52w low+50.44%
New 52w highNo
SqueezeOff
Bollinger width7.49%
%B0.59
Donchian pos57.93%
Donchian high215.52
Donchian low200.52
AVWAP (52w high)208.23
vs AVWAP high+0.47%
AVWAP (52w low)173.99
vs AVWAP low+20.25%
OBV trendFlat
Chaikin MF (20)-0.02
Today vs 20d0.66×
Avg vol (14d)1.49M
Avg vol (20d)1.48M
Avg $ vol (20d)307.31M
Market cap—
RS Rating88 / 99
RS 3m (vs SPY)+9.41%
RS 6m (vs SPY)+9.40%
RS line new highNo
Trend template8/8
Technical rank81.2
1 week+1.03%
1 month-3.32%
3 months+13.91%
6 months+26.22%
1 year+46.82%
YTD+23.79%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeXNAS
Shares out46.95M
Employees—
ListedMon, Feb 5, 2001
Free float—
Float %—
Short interest10.99M
Days to cover6.6d
Short volume47.2%
Squeeze score50 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction79 / 100
Pattern quality—
Tech rank81.2 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance216.50
Support189.96
Days since event—
Candle confirm—

Congress activity

Disclosed STOCK Act trades in IBB

All disclosures →
No recent disclosed trades by Congress in IBB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IBB

No recent insider (Form 4) filings in IBB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in IBB

EDGAR →

No recent SEC filings on file for IBB.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.